Haploidentical donor bone marrow transplantation (BMT) for advanced hematologic malignancy (HM) following non-myeloablative preparative therapy: Role of in vivo T-cell depletion with anti-thymocyte globulin or anti-CD2 monoclonal antibody therapy (MEDI-507).

被引:0
|
作者
Spitzer, TR [1 ]
McAfee, S [1 ]
Sackstein, R [1 ]
Dey, B [1 ]
Colby, C [1 ]
Grossberg, H [1 ]
Hope, J [1 ]
Saidman, S [1 ]
Preffer, F [1 ]
Alexander, S [1 ]
Sachs, DH [1 ]
Sykes, M [1 ]
机构
[1] Harvard Univ, Sch Med, BioTransplant Inc, Massachusetts Gen Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3633
引用
收藏
页码:841A / 841A
页数:1
相关论文
共 6 条
  • [1] Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507
    Zhang, Z
    Zhang, ML
    Ravetch, JV
    Goldman, C
    Waldmann, TA
    BLOOD, 2003, 102 (01) : 284 - 288
  • [2] Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies
    Spitzer, TR
    McAfee, SL
    Dey, BR
    Colby, C
    Hope, J
    Grossberg, H
    Preffer, F
    Shaffer, J
    Alexander, SI
    Sachs, DH
    Sykes, M
    TRANSPLANTATION, 2003, 75 (10) : 1748 - 1751
  • [3] Haploidentical donor BMT for advanced hematologic malignancy (HM) following non-myeloadlative conditioning including in vivo T-cell depletion.
    Spitzer, TR
    McAfee, S
    Sackstein, R
    Dey, B
    Colby, C
    Grossberg, H
    Hope, J
    Saidman, S
    Preffer, F
    Sachs, DH
    Sykes, M
    LEUKEMIA, 2002, 16 (03) : 415 - 415
  • [4] Effective therapy for murine model of adult T-cell leukemia with anti-CD2 monoclonal antibody, MEDI-507.
    Zhuo, Z
    Zhang, ML
    Mandler, R
    Goldman, C
    Morris, JC
    Janick, JE
    Waldmann, TA
    BLOOD, 2002, 100 (11) : 763A - 763A
  • [5] Induction of mixed chimerism and potent anti-tumor responses following non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation (BMT) for refractory hematologic malignancies (HM).
    Spitzer, TR
    McAfee, SL
    Sackstein, R
    Toh, HC
    Saidman, S
    Weymouth, D
    Preffer, F
    Colby, C
    Sachs, DH
    Sykes, M
    BLOOD, 1998, 92 (10) : 519A - 519A
  • [6] Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion
    Chen, HR
    Ji, SQ
    Wang, HX
    Yan, HM
    Zhu, L
    Liu, J
    Xue, M
    Xun, CQ
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (11) : 1019 - 1025